BioSpace News Archive

Business

Flexion Therapeutics Announces the Retirement of Neil Bodick, M.D., Ph.D., Chief Scientific Officer and Company Co-Founder

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Neil Bodick, M.D., Ph.D., Chief Scientific Officer, will retire effective January 3, 2020.

December 10, 2019
·
5 min read
Policy

Tetra Bio-Pharma Provides Update on its Hepatocellular Carcinoma Drug HCC011

Tetra Bio-Pharma Inc. announced it will be requesting a meeting with the U.S. Food and Drug Administration to discuss the drug development program for its Orphan Drug candidate HCC011, inhaled delta-9-tetrahydrocannabinol, in the treatment of hepatocellular carcinoma.

December 10, 2019
·
6 min read
Pharm Country

Stemline Therapeutics Recaps ELZONRIS Clinical Data Presentations in Patients with Myelofibrosis (oral presentation) and Multiple Myeloma at the 61st American Society of Hematology (ASH) Annual Meeting

Stemline Therapeutics, Inc. presented data from ELZONRIS® Phase 1/2 clinical trials in myelofibrosis and multiple myeloma, at the 2019 ASH annual meeting.

December 10, 2019
·
8 min read
Business

DARZALEX® (Daratumumab) Regimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma

First Phase 3 study showing addition of the CD38-directed antibody DARZALEX® to carfilzomib in combination with dexamethasone

December 10, 2019
·
22 min read
Business

EMD Serono and the pan-Canadian Pharmaceutical Alliance Complete Negotiations for MAVENCLAD® (cladribine tablets) for the treatment of Relapsing-Remitting Multiple Sclerosis

This an important next step to ensure broader access to PrMAVENCLAD® for eligible Canadians living with Relapsing-Remitting Multiple Sclerosis

December 10, 2019
·
5 min read
BioMidwest

Athletico Physical Therapy Announces 7th Annual Coach of the Year Award Winner

Athletico Physical Therapy is proud to announce Missy Mason of Amos Alonzo Stagg High School in Palos Heights, Illinois as the winner of the 7th Annual Athletico Coach of the Year Award.

December 10, 2019
·
3 min read
Policy

Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device

Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the receipt of an Investigational Device Exemption from the FDA – enabling the company to conduct the first long-term clinical trial of its ultra-miniaturized neuromodulation platform.

December 10, 2019
·
2 min read
Policy

CNS Pharmaceuticals Received Positive FDA Pre-IND Guidance for Berubicin

CNS Pharmaceuticals, Inc., a biotechnology company specializing in the development of novel treatments for brain tumors, received positive feedback from the U.S. Food and Drug Administration for its Pre-IND meeting proposal to use a lyophilized drug product, Berubicin, in Phase II clinical trials..

December 10, 2019
·
4 min read
Business

Locana Expands Leadership Team with Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer

Locana, Inc. announced the appointment of James Burns, Ph.D., as chief executive officer, as a key step in expanding the experienced leadership team and as part of a planned transition of the company’s director and recent CEO, Jeffrey M. Ostrove, Ph.D., to continue service as director..

December 10, 2019
·
2 min read
Genetown

Innovative Healthcare Startup Kermit Leverages Mendix-built Analytics Platform to Expand Services Nationwide

After being proven in 23 mid-Atlantic hospitals for a combined $75 million per year in medical cost savings, healthcare analytics platform created with Mendix’s low-code rapid application development provides foundation for Kermit’s national expansion

December 10, 2019
·
6 min read